Restraint Before Prescribing Acid-Suppressive Therapy
According to an article published in Critical Care Nurse, the routine use of acid-suppressive therapy for all hospitalised patients including all critically ill patients, is inappropriate and should only be limited to patients who actually need them and meet specific criteria.
Due to the fact that critically ill patients are at an increased risk of gastrointestinal ulceration and bleeding, it has become a standing practice to give them stress ulcer prophylaxis (SUP). Not only is this very common for all ICU patients but has now migrated to noncritically ill patients as well.
However, in this new review, the authors suggest that giving acid-suppressive therapy to all hospitalised patients may put them at a higher risk of pneumonia, Clostridium difficile infection and other infections.
Co-author Andrew Faust, a critical care clinical pharmacist at Texas Health Presbyterian Hospital Dallas explains that suppressing gastric acid may be necessarily in some critically ill patients but doing so affects its effectiveness as an antiseptic barrier. Using such therapy, especially through proton pump inhibitors could increase the risk of serious and life-threatening infectious complications.
Based on a thorough review, the authors conclude that the benefit of acid-suppressive therapy in critically ill patients as well as other patients who are a low risk of GI bleeding is outweighed by the risk of infection associated with this therapy.
The most common indications for SUP include mechanicical ventilation for longer than 48 hours, traumatic brain injury, spinal cord injury and respiratory failure. Minor risk factors such as sepsis syndrome, history of alcohol abuse, long surgery over four hours, renal failures and other conditions are not associated with GI bleeding. The authors propose that when risk factors are no longer present or when patients are transferred out of the ICU, SUP should be reevaluated and discontinued.
Source: American Association of Critical-Care Nurses (AACN)
Image Credit: Pixabay
Published on : Fri, 2 Jun 2017
Q-NRG is the first Indirect Calorimeter specifically intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing and for healthy subjects. Q-NRG is a unique product, resulting...
Stay informed at every point of care In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings...
The HAMILTON-S1 is one of the most advanced mechanical ventilators with a number of unique features. It was the first ventilator featuring the "Ventilation Autopilot" INTELLiVENT®-ASV®. · Automated control of the patient’s Ventilation
A high-end ventilator featured with 1080P HD wide screen, combines an intuitive customized UI with powerful assistive tools and modules. Operate with Ease In the modern busy clinical environment, ease of use is a fundamental requirement for all...
The HAMILTON-C6 represents a new Generation of high-end ventilators. The combination of modularity, ease of use, mobility, and advanced features allows you to individualize your patient's ventilation therapy: - State-of-the-art ventilation modes for...